Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Bortezomib as a Treatment Option in Patients With Waldenström Macroglobulinemia — Meletios A Dimopoulos (2010) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Bortezomib as a Treatment Option in Patients With Waldenström Macroglobulinemia
Shared by
Meletios A Dimopoulos
Bortezomib as a Treatment Option in Patients With Waldenström Macroglobulinemia
Article
2010
en
Authors
+2 more
Meletios A Dimopoulos
CC
Christine Chen
EK
Efstathios Kastritis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2005
Treatment of relapsed or refractory Waldenström's macroglobulinemia with bortezomib.
Meletios A Dimopoulos
,
Athanasios K. Anagnostopoulos
,
Maria Christina Kyrtsonis
,
Efstathios Castritis
,
Athanasios Bitsaktsis
,
Gerassimos A. Pangalis
Article
2002
Treatment of Waldenström’s Macroglobulinemia With Rituximab
Meletios A Dimopoulos
,
Constantinos Zervas
,
Athanassios Zomas
,
Christos Kiamouris
,
Nora Viniou
,
Vassiliki Grigoraki
,
Christos Karkantaris
,
Chrisanthi Mitsouli
,
Dimitra Gika
,
John Christakis
,
Nikolaos Anagnostopoulos
Letter
2001
Treatment of Waldenstrom’s Macroglobulinemia With Thalidomide
Meletios A Dimopoulos
,
Athanassios Zomas
,
Nora Viniou
,
Vassiliki Grigoraki
,
Eleni Galani
,
Charis Matsouka
,
Olga Economou
,
Nikolaos Anagnostopoulos
,
Panayiotis Panayiotidis
Chapter in a book
2016
Treatment Recommendations in Waldenström Macroglobulinemia
Véronique Leblond
,
Meletios A Dimopoulos
,
Steven P. Treon
Article
2007
Treatment of Waldenstrom’s Macroglobulinemia
Meletios A Dimopoulos
,
Athanasios K. Anagnostopoulos
Discussion(0)
No comments yet. Be the first to comment.